Ticker brief
RZLT
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
7
authors 14d
4
crowd 14d
+0.6σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-15 · now +0.00 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BiopharmIQ | B | · | 3 | +0.00 |
| @BioStocks | C | -1.77 | 2 | +0.20 |
| @Greatstockpix | C | -1.40 | 1 | +0.00 |
| @OzmosiHealth | C | · | 1 | +0.15 |
Recent signals7of 7 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-15 | @BiopharmIQ | +0.00 | The tweet lists large opening biotech moves and upcoming Phase 3 catalysts. | · | tweet ↗ |
| 2026-10-14 | @OzmosiHealth | +0.15 | Rezolute completed enrollment in the Phase 3 upLIFT study. | · | tweet ↗ |
| 2026-10-09 | @BiopharmIQ | +0.00 | Summarizes large biotech moves tied to a buyout and trial outcomes, then flags upcoming studies. | · | tweet ↗ |
| 2026-10-08 | @BiopharmIQ | +0.00 | Summarizes large biotech moves and lists upcoming Phase 2 and Phase 3 catalysts. | · | tweet ↗ |
| 2026-10-05 | @BioStocks | +0.40 | Reports Cantor upgrading RZLT to Overweight. | · | tweet ↗ |
| 2026-10-05 | @Greatstockpix | +0.00 | Daily watchlist video lists numerous tickers without specific entry intent; first six retained. | · | tweet ↗ |
| 2026-10-05 | @BioStocks | +0.00 | Phase 3 upLIFT topline data are expected this quarter. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.